Machavert Pharmaceuticals
PrivateLast Round
Series A
Feb 11, 2019
Total Funding Raised
$2.45M
Company Overview
Machavert Pharmaceuticals is a drug discovery company that develops novel, first-in-class therapeutics for the treatment of cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Machavert Pharmaceuticals Comparables
Compare Machavert Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quanta Therapeutics | 81% | |
| SciBrunch Therapeutics | 78% | |
| Revolution Medicines | 76% |
For institutional investors. Book with your work email.
Machavert Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 11, 2019 | ||||
| Grant | Nov 19, 2018 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 11, 2019
$2.2M round completed.
- Nov 19, 2018
$250K grant received from the State of Colorado.
For institutional investors. Book with your work email.
Machavert Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Machavert Pharmaceuticals's valuation, stock price, and market status.
Is Machavert Pharmaceuticals a public or private company?
Machavert Pharmaceuticals is a private company.
What is the current stock price of Machavert Pharmaceuticals?
Machavert Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Machavert Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Machavert Pharmaceuticals worth (valuation)?
Valuation information for Machavert Pharmaceuticals is not publicly available.
Can I buy Machavert Pharmaceuticals stock?
Machavert Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Machavert Pharmaceuticals's last funding round?
Machavert Pharmaceuticals's most recent funding round was Series A on February 11, 2019.
Who are the main investors in Machavert Pharmaceuticals?
Investor information for Machavert Pharmaceuticals is not publicly disclosed.
Will Machavert Pharmaceuticals IPO soon?
No public IPO plans have been announced for Machavert Pharmaceuticals.
How can I track Machavert Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Machavert Pharmaceuticals's shares on secondary markets.